Intellectual Property India Publishes Patent Application for 'Heterocyclic Compounds As Wrn Inhibitors' Filed by Synnovation Therapeutics, Inc.

MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202517093332 A) filed by Synnovation Therapeutics, Inc., Wilmington, U.S.A., on Sept. 29, for 'heterocyclic compounds as wrn inhibitors.'

Inventor(s) include Yang, Jeffrey; Bai, Yu; He, Chunhong; Zhou, Fei; You, Lin; Mukai, Ken; Zheng, Hewen; Li, Yu; Zhang, Fenglei; Qi, Chao; Wu, Liangxing; and Yao, Wenqing.

The application for the patent was published on Oct. 31, under issue no. 44/2025.

According to the abstract released by the Intellectual Property India: "The present application provides heterocyclic compounds that modulate the activity of Werner syndrome helicase (WRN), and are useful in the treatment of various diseases, including cancer."

The patent application was internationally filed on Mar. 07, 2024, under International application No.PCT/US2024/018967.

Disclaimer: Curated by HT Syndication.